The immune system sits at the heart of human health. And as research digs deeper into its complexity, its role in shaping treatment and prevention is only getting bigger. The latest Industry Focus eBook looks at where immunology is headed—how discoveries in the lab are making their way into clinics and changing the way we approach disease.
Download your copy of the eBook now to learn more!
Inside, you’ll find stories that span from targeted topical therapies to big-picture public health. We explore the promise of immunotherapy for preventing precancerous skin lesions, the health risks linked to Candida overgrowth in the gut, and the surprising ways inflammation can both help and harm recovery. We also tackle public health questions like whether vitamin D deficiency could be driving immune-related fatigue, and put the raw milk safety debate under the microscope.
This edition doesn’t shy away from the lasting imprint of the COVID-19 pandemic either, including its connection to autoimmune and autoinflammatory disorders.
Sponsored by Sino Biological, the eBook also features expert voices to highlight where immunology could take us next—from kinase inhibitors for neurodegenerative diseases to targeted therapies for autoimmune conditions to the role of cytokines in disease progression and treatment.
Download your copy of the eBook now to learn more!
About Sino Biological Inc
Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones. Sino Biological is the researchers' one-stop technical services shop for the advanced technology platforms they need to make advancements. In addition, Sino Biological offer pharmaceutical companies and biotechnology firms pre-clinical production technology services for hundreds of monoclonal antibody drug candidates.
Sino Biological's core business
Sino Biological is committed to providing high-quality recombinant protein and antibody reagents and to being a one-stop technical services shop for life science researchers around the world. All of our products are independently developed and produced. In addition, we offer pharmaceutical companies and biotechnology firms pre-clinical production technology services for hundreds of monoclonal antibody drug candidates. Our product quality control indicators meet rigorous requirements for clinical use samples. It takes only a few weeks for us to produce 1 to 30 grams of purified monoclonal antibody from gene sequencing.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.